Drug repurposing, in which an established active pharmaceutical ingredient is applied in a new way — for example, in a new presentation, often combined with a new therapeutic indication — is an evolving strategy for pharmaceutical R&D. This article discusses each aspect of this strategy, highlighting commercial successes that have arisen from a focus on the presentation and therapeutic use of known active ingredients or slight variations of these compounds.
